Grace Therapeutics
NASDAQ: GRCE
$2.12
as on
Grace Therapeutics Stock Performance
as on September 28, 2026 at 2:16 pm IST
Day's Low
Day's High
$2.10$2.14
0.94%
Downside
0.94%
Upside
52 Week's Low
52 Week's High
$1.79$5.1815.57%
Downside
144.34%
Upside
Grace Therapeutics share price movements today
- Previous Close
- $2.16
- Open
- $2.14
- Volume
- 883.9K
- Market Cap
- $44.6M
- Day's Low - High
- $2.10 - $2.14
- 52 Week Low - High
- $1.79 - $5.18
Grace Therapeutics Historical Returns
- 1 Month Return
- 0 %
- 3 Month Return
- -10.92 %
- 1 Year Return
- -31.39 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Grace Therapeutics Stock Fundamentals & Key Indicators
Check Grace Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$44.6M
EPS (TTM)
-1.2557
Dividend Yield
0.00%
PE Ratio (TTM)
-1.69
Industry PE ratio
-2.64
PEG Ratio
0.013042786759214555
Return On Equity TTM
-35.78%
Grace Therapeutics Stock Valuation
Track how Grace Therapeutics P/E has moved over time to understand its valuation trends.
Grace Therapeutics in the last 5 years
Lowest (-9.85x)
March 31, 2026
Today (-9.85x)
March 31, 2026
Industry (-2.64x)
March 31, 2026
Highest (-0.53x)
March 31, 2023
Today’s Price to Earnings Ratio: -9.85x
Grace Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Grace Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $44.6M | NA | -1.69 | 0.00% | 0.00% | |
| StrongBuy | $43.9B | 615.18% | -23.13 | 0.00% | 0.00% | |
| Neutral | $79.4B | -48.24% | -24.92 | -12.57% | 0.00% | |
| StrongBuy | $133.4B | 189.75% | 30.38 | 86.04% | 0.00% | |
| Buy | $81.1B | 30.25% | 18.82 | 84.86% | 0.47% |
Stock Returns calculator for Grace Therapeutics Stock including INR - Dollar returns
The Grace Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Grace Therapeutics investment value today
Current value as on today
₹74,236
Returns
Returns from Grace Therapeutics Stock
Dollar Impact
₹5,628 (+5.63%)
Analyst Recommendation on Grace Therapeutics Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Grace Therapeutics. Average target price of $4
Indian Investors' Interest in Grace Therapeutics Stock
Search interest for Grace Therapeutics Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Grace Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Grace Therapeutics Annual Profit & Loss
All numbers in Millions USD
Grace Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Grace Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Grace Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 98.3% return, outperforming this stock by 126.4%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 743.5%
NEGATIVE IMPACTPrice Dip
In the last 6 months, GRCE stock has moved down by -54.6%
About Grace Therapeutics
| Organisation | Grace Therapeutics |
| Headquarters | 103 Carnegie Center, Princeton, NJ, 08540, US |
| Industry | Biotechnology |
| CEO | Prashant Kohli |
| E-voting on shares | Click here to vote |
Key Management of Grace Therapeutics
Name | Title |
|---|---|
Mr. Prashant Kohli | CEO & Director |
Mr. Amresh Kumar Ph.D. | VP of Program Management |
Ms. Carrie D'Andrea | Consultant |
Mr. Robert J. DelAversano CPA | VP of Finance and Principal Financial & Accounting Officer |
Dr. R. Loch MacDonald M.D., Ph.D. | Member of Scientific Advisory Board & Chief Medical Officer |
FAQs
What is Grace Therapeutics share price today?
Grace Therapeutics share price today is $2.12 as on at the close of the market. Grace Therapeutics share today touched a day high of $2.14 and a low of $2.10.
What is the 52 week high and 52 week low for Grace Therapeutics share?
Grace Therapeutics share touched a 52 week high of $5.18 on and a 52 week low of $1.79 on . Grace Therapeutics stock price today i.e. is closed at $2.12,which is 59.07% down from its 52 week high and 18.44% up from its 52 week low.
What is Grace Therapeutics's market capitalisation today?
Grace Therapeutics market capitalisation is $0.00T as on .
How to invest in Grace Therapeutics Stock (GRCE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Grace Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Grace Therapeutics Shares that will get you 0.7075 shares as per Grace Therapeutics share price of $2.12 per share as on September 28, 2026 at 8:46 am IST.
What is the minimum amount required to buy Grace Therapeutics Stock (GRCE) from India?
Indian investors can start investing in Grace Therapeutics (GRCE) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Grace Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Grace Therapeutics share’s latest price of $2.12 as on September 28, 2026 at 8:46 am IST, you will get 4.7170 shares of Grace Therapeutics. Learn more about
fractional shares .